17q12, explained for kidsdeletion syndrome · static snapshot
Adults Scientists Kids EN NL
Everything here was found on the internet and put together with help from a computer program that reads and writes (AI). It is here so you can learn — it is not the final word. Always check the real source. Read the whole notice
Something new reported Kidneys and diabetes 1 supporting source confidence 97% novelty 90%

Someone reported something new: The current study describes the first case of MODY 5 treated with the GLP-1RA, liraglutide, which exerted prot…

A source describes a new or expanded observation: “The current study describes the first case of MODY 5 treated with the GLP-1RA, liraglutide, which exerted protective effects against pancreatic beta cell dysfunction. [ 11 , 12 ] 2 Case report A 17-year-old woman with a 3-month history of thirst, polydipsia, and polyuria underwent urine glucose scre”

More something new reported

How this was derived

Flagged by novelty language (“for the first time”, “expands the phenotype”, …) in pubmed.

Generated 2026-11-13, last changed today. Dedup key expansion:9a6007. The engine re-checks this insight on every analysis run; if more sources agree, its corroboration and confidence go up and it reappears as “new”.

Evidence (1 quote)

Semaglutide as a potential therapeutic alternative for HNF1B-MODY: a case study. peer_reviewed · published 2024-01-01 · live page
The current study describes the first case of MODY 5 treated with the GLP-1RA, liraglutide, which exerted protective effects against pancreatic beta cell dysfunction. [ 11 , 12 ] 2 Case report A 17-year-old woman with a 3-month history of thirst, polydipsia, and polyuria underwent urine glucose screening at school where glucosuria was detected for the first time.

Supporting documents (1)

StorySourcePublishedSeenRelevance
Semaglutide as a potential therapeutic alternative for HNF1B-MODY: ... pubmed 2024-01-01 yesterday 1.00